In vivo, specific anti-La/SSB antibody binding to tumours is facilitated by the inefficient post-chemotherapy clearance of dead cancer cells in contrast to the rapid and barely detectable clearance of apoptotic cells in normal tissues [19]. The gene discussed is SSB; the disease is neoplasm.